Phosphorylation of the carboxyl terminal domain (CTD) of RNA polymerase II by TFIIH would

In CTD Module 3.2.S, why is the date of manufacture of the final active pharmaceutical ingredient (API) important? (1)

Mean dissolution (%):   Time minutes Ref Test    10 30 35   15 55 60   20 75 80   30 90 92    Calculated f₂ ≈ 52. Variability of test at 15 min = 22 %. Which of the following statements is correct?

Which of the following conditions is required for valid f₂ comparison?

During pharmaceutical transport, temperature fluctuations frequently occur, which can impact product stability. Which statement best describes the use of Mean Kinetic Temperature (MKT)?

A batch of immediate-release tablets has a dissolution specification of Q = 80 % in 30 minutes:                                                                                                                                      (15)The % dissolved at 30 minutes is measured as follows:   Tablet % Dissolved    S1 (6 tablets) 82, 79, 84, 81, 78, 80   S2 (6 tablets) 83, 85, 79, 80, 81, 82   S3 (12 tablets) 80, 79, 81, 82, 78, 83, 80, 81, 82, 80, 79, 81  Tasks:Calculate the mean % dissolved at tier (S2, S3 as required).Determine whether and at what stage the batch meets the dissolution specification.Explain the regulatory implications of your findings at each tier.

Which guideline governs residual solvents in APIs?

A highly soluble, low permeability API pharmaceutical product has different excipients in test vs reference products. Biowaiver is:

How can the cost of a bioequivalence study be reduced through appropriate selection of pharmacokinetic sampling times?

The liver seems homogeneous in this image.